🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Novel antibodies against follicular non-Hodgkin’s lymphoma

Best Practice & Research Clinical Haematology(2011)10.1016/j.beha.2011.03.002Source: DataRank Database

Novel antibodies against follicular non-Hodgkin’s lymphoma is a research paper published in Best Practice & Research Clinical Haematology (2011). On theSindex it has a DataRank of 1.2. It has been cited 25 times, with 24 citing works in its 1-hop citation network.

N/A
1.2DataRank · unranked
1.2
25 citations · base score 3.3
Cite:
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Data sources & pipeline
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (0/2)
    Interoperable (0/2)
      Reusable (0/3)

        FAIR checklist signals are shown for context only and do not affect DataRank scoring.

        DataRank Breakdown

        Base Score 40%Citation Network 60%

        Base Score Contribution

        0.489

        From this paper's citation signal

        Citation Network Contribution

        0.724

        From 18 citing papers with measurable signal

        Learn more about DataRank methodology →

        Top 3 citers driving the network score

        Ranked by citation count — the same ordering the engine uses when summing log1p(Cq) over citers.

        1. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
          New England Journal of Medicine200410,954 citationsDataRank 1.4
        2. CD20-Targeted Therapy: The Next Generation of Antibodies
          Seminars in Hematology201092 citationsDataRank 4.6
        Why this DataRank?

        DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 40% comes from its base citations and 60% from the citation network (18 citing papers contributed measurable signal).

        Base score B(p)
        log1p(citation_count) — grows sub-linearly, so a paper with 1,000 citations is not 10× a paper with 100.
        Network N(p)
        Σ over citers of log1p(Cq) ÷ max(outdegreeq, 1). Being cited by a highly-cited paper with few references counts most.
        Damping factor d = 0.85
        DataRank = (1−d)·B(p) + d·N(p) — the two cards above are each already multiplied by their share.
        Self-citations excluded
        Citers sharing any OpenAlex author ID with this paper are filtered out before the network sum.

        Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.

        Read the full methodology →

        Click a node to highlight its connections. Use scroll to zoom. Drag to pan.

        Node colors:CenterData PaperData + Open AccessNon-dataSelected & links| Node size = percentile rank

        Authors (2)

        Anton Hagenbeek,Tom van Meerten

        Related Papers (10)

        Best Practice & Research Clinical Haematology(2011)
        OpenAlex related
        10.1016/j.beha.2011.03.002
        European Journal of Nuclear Medicine and Molecular Imaging(2008)
        OpenAlex related
        10.1007/s00259-008-0727-z